文献速递淋巴瘤

双打击特征可识别FISH难以检测的双打击弥漫大B细胞淋巴瘤

The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH.
PubMed 文献 · Blood · 2019-01-01

研究对20例双打击特征阳性但FISH未检出MYC和/或BCL2重排的生发中心B细胞样弥漫大B细胞淋巴瘤行全基因组测序,发现6例存在FISH隐匿的MYC或BCL2重排,并发现MIR17HG增益/扩增和PVT1启动子局灶缺失等可能致MYC失调的机制。结果表明FISH会漏检部分高级别B细胞淋巴瘤,基因表达谱对识别预后不良的生物学基础更敏感。

要点

  • 双打击特征阳性DLBCL中仅半数FISH可检出MYC和BCL2易位。
  • 全基因组测序可发现FISH隐匿的MYC或BCL2重排。
  • MIR17HG增益/扩增和PVT1启动子缺失可能参与MYC失调。

核心结论

  • FISH无法识别所有双打击/三打击高级别B细胞淋巴瘤,基因表达谱对识别预后不良的生物学基础更敏感。

研究设计与样本

  • 对20例双打击特征阳性且FISH未检出MYC和/或BCL2重排的生发中心B细胞样弥漫大B细胞淋巴瘤行全基因组测序。

主要发现

  • 全基因组测序发现6例肿瘤存在FISH隐匿的MYC或BCL2重排。
  • 拷贝数分析发现3例肿瘤有MYC增益、6例有MIR17HG增益或扩增。
  • PVT1启动子局灶缺失仅见于缺乏MYC易位的双打击特征阳性肿瘤。

临床怎么用

  • 对FISH阴性的生发中心B细胞样弥漫大B细胞淋巴瘤,可考虑基因表达谱识别双打击特征以评估不良预后。

局限性

  • 样本量较小(20例),结论需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements (HGBL-DH/THs) include a group of diffuse large B-cell lymphomas (DLBCLs) with inferior outcomes after standard chemoimmunotherapy. We recently described a gene expression signature that identifies 27% of germinal center B-cell DLBCLs (GCB-DLBCLs) as having a double-hit-like expression pattern (DHITsig) and inferior outcomes; however, only half of these cases have both MYC and BCL2 translocations identifiable using standard breakapart fluorescence in situ hybridization (FISH). Here, 20 DHITsig+ GCB-DLBCLs apparently lacking MYC and/or BCL2 rearrangements underwent whole-genome sequencing. This revealed 6 tumors with MYC or BCL2 rearrangements that were cryptic to breakapart FISH. Copy-number analysis identified 3 tumors with MYC and 6 tumors with MIR17HG gains or amplifications, both of which may contribute to dysregulation of MYC and its downstream pathways. Focal deletions of the PVT1 promoter were observed exclusively among DHITsig+ tumors lacking MYC translocations; this may also contribute to MYC overexpression. These results highlight that FISH fails to identify all HGBL-DH/THs, while revealing a range of other genetic mechanisms potentially underlying MYC dysregulation in DHITsig+ DLBCL, suggesting that gene expression profiling is more sensitive for identifying the biology underlying poor outcomes in GCB-DLBCL.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Hilton LK, Tang J, Ben-Neriah S, et al. The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH. Blood. 2019. PMID: 31527075. doi:10.1182/blood.2019002600

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。